4519 — Chugai Pharmaceutical Co Balance Sheet
0.000.00%
- ¥11tn
- ¥10tn
- ¥1tn
- 99
- 22
- 29
- 49
Annual balance sheet for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | — | — | IFRS | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 378,620 | 471,970 | 503,107 | 738,982 | 996,345 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 253,354 | 356,009 | 514,283 | 320,348 | 335,152 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 834,906 | 1,063,661 | 1,336,537 | 1,366,426 | 1,606,043 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 297,490 | 352,107 | 386,651 | 420,701 | 441,554 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,235,498 | 1,538,694 | 1,869,758 | 1,932,547 | 2,208,373 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 236,070 | 327,422 | 423,730 | 288,217 | 290,357 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 255,495 | 350,677 | 445,371 | 306,967 | 306,874 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 980,003 | 1,188,017 | 1,424,387 | 1,625,580 | 1,901,499 |
| Total Liabilities & Shareholders' Equity | 1,235,498 | 1,538,694 | 1,869,758 | 1,932,547 | 2,208,373 |
| Total Common Shares Outstanding |